Risk-adapted therapy for young children with medulloblastoma (SJYC07): results and molecular analysis from a multicenter phase II trial

BACKGROUND: Young children with medulloblastoma have inferior survival to older children. While the principal difference is due to radiation-sparing therapy, radiation is not an absolute requisite for survival of all. We aimed to estimate the event-free survival of young medulloblastoma patients wit...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Lancet Oncol
Main Authors: Robinson, Giles W., Rudneva, Vasilisa A., Buchhalter, Ivo, Billups, Catherine A., Waszak, Sebastian M., Smith, Kyle S., Bowers, Daniel C., Bendel, Anne, Fisher, Paul G., Partap, Sonia, Crawford, John R., Hassall, Tim, Indelicato, Daniel J., Boop, Frederick, Klimo, Paul, Sabin, Noah D., Patay, Zoltan, Merchant, Thomas E., Stewart, Clinton F., Orr, Brent A., Korbel, Jan O., Jones, David T.W., Sharma, Tanvi, Lichter, Peter, Kool, Marcel, Korshunov, Andrey, Pfister, Stefan M., Gilbertson, Richard J., Sanders, Robert P., Onar-Thomas, Arzu, Ellison, David W., Gajjar, Amar, Northcott, Paul A.
Format: Artigo
Jezik:Inglês
Izdano: 2018
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6078206/
https://ncbi.nlm.nih.gov/pubmed/29778738
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S1470-2045(18)30204-3
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki